In addition, Zhang et al. combined nanotechnology and genome engineering to disrupt cyclin-dependent kinase 5 (Cdk5), resulting in markedly decreased expression of PD-L1 on tumor cells, effectively inhibiting growth of mouse melanoma and TNBC lung metastasis [154]. The gene discussed is CDK5; the disease is neoplasm.